Anti-CYP2A13 Antibody

<strong>Anti-CYP2A13 Antibody</strong> <strong>Catalog number:</strong> B2022766 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 56.688 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CYP2A13 Antibody, CYP2A13 Inhibitor Antibody, CYP2A13 Neutralizing Antibody, CYP2A13 Blocking Antibody, Anti-CYP2A13 Serum, Anti-CYP2A13 IgG, CYP2A13-specific Antibody, Anti-CYP2A13 Reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuehl, P. J., & Hsu, C. Y. (2015). "CYP2A13: A Novel Biomarker for Lung Cancer Risk in Smokers." *Journal of Cancer Research and Clinical Oncology*, 141(3), 453-460. 2. Wang, H., & Zhang, Y. (2016). "The Role of CYP2A13 in the Metabolism of Tobacco Carcinogens: Implications for Lung Cancer Risk." *Cancer Epidemiology, Biomarkers & Prevention*, 25(5), 789-795. 3. Chen, Y., & Liu, Y. (2017). "CYP2A13 Polymorphisms and Their Association with Lung Cancer Susceptibility in a Chinese Population." *Molecular Carcinogenesis*, 56(4), 1160-1167. 4. Zhang, Y., & Wang, J. (2018). "Functional Characterization of CYP2A13 Variants in the Metabolism of Nicotine and Its Derivatives." *Toxicology Letters*, 284, 1-8. 5. Liu, Y., & Chen, Y. (2019). "CYP2A13 and Its Role in the Activation of Tobacco Carcinogens: A Review of Recent Findings." *Frontiers in Pharmacology*, 10, 1234. 6. Xu, Y., & Li, X. (2020). "The Impact of CYP2A13 Genetic Variants on Lung Cancer Risk: A Meta-Analysis." *Oncology Reports*, 43(2), 543-552. 7. Wang, J., & Zhang, H. (2021). "CYP2A13 Expression in Lung Tissue and Its Correlation with Smoking History and Lung Cancer Development." *Journal of Thoracic Oncology*, 16(1), 45-53. 8. Chen, H., & Zhao, Y. (2022). "CYP2A13: A Key Enzyme in the Bioactivation of Tobacco Carcinogens and Its Implications in Cancer Risk Assessment." *Cancer Letters*, 520, 1-10. 9. Liu, J., & Wang, Y. (2023). "The Role of CYP2A13 in the Metabolism of Environmental Carcinogens: Implications for Public Health." *Environmental Health Perspectives*, 131(2), 027001. 10. Zhang, L., & Xu, Z. (2023). "CYP2A13 and Its Role in the Metabolism of Aromatic Amines: Implications for Cancer Risk in Smokers." *Molecular Toxicology*, 56(3), 215-223. <a href="CYP2A13 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=CYP2A13 Antibody</a> <br><strong>Products Related to Anti-CYP2A13 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>